QURE uniQure N.V.
Healthcare$25.15+3.97%ClosedMarket Cap: $1.57B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
10.16
P/S
83.60
EV/EBITDA
-9.27
DCF Value
$-8.05
FCF Yield
-11.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
74.1%
Operating Margin
-1057.5%
Net Margin
-1154.4%
ROE
-145.8%
ROA
-26.8%
ROIC
-26.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $3.6M | 93.9% | $-44.3M | $-53.5M | $— | — |
| Q4 null | $5.6M | 38.8% | $-52.2M | $-37.1M | $— | — |
| FY null | $16.1M | 89.5% | $-187.8M | $-199.0M | $— | — |
| Q3 null | $3.7M | 89.2% | $-51.0M | $-80.5M | $— | — |
| Q2 null | $5.3M | 87.5% | $-43.9M | $-37.7M | $— | — |
| Q1 null | $1.6M | 87.4% | $-39.3M | $-43.6M | $— | — |
| Q4 null | $5.2M | 88.1% | $-45.8M | $-73.3M | $— | — |
| FY null | $27.1M | 32.4% | $-184.3M | $-239.6M | $— | — |
| Q3 null | $2.3M | 55.4% | $-40.2M | $-44.4M | $— | — |
| Q2 null | $11.1M | 32.9% | $-44.0M | $-56.3M | $— | — |
| Q1 null | $8.5M | -8.7% | $-54.2M | $-65.6M | $— | — |
| Q4 2023 | $6.7M | -32.1% | $-61.7M | $-73.2M | $-1.53 | — |